endocrine and targeted therapy for hr-positive, her2-negative metastatic breast cancer – capivase...
Published 6 months ago • 21 plays • Length 14:09Download video MP4
Download video MP3
Similar videos
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
3:15
investigating targeted therapy combinations in metastatic hr breast cancer
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
53:02
medical update: hormone receptor-positive metastatic breast cancer
-
7:36
asco 2022: metastatic breast cancer drug therapy recap
-
1:03:02
report from asco focusing on metastatic breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
1:14
endocrine therapy resistance in er metastatic breast cancer
-
7:00
upfront treatment of hr-positive metastatic breast cancer
-
7:01
strategies for hormone receptor-positive metastatic bc
-
6:32
abemaciclib with endocrine as frontline therapy
-
21:57
the best sequence of endocrine treatment in metastatic luminal breast cancer:solving the puzzle
-
5:35
case 2: treatment recommendations for er breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer